Related Experiment Videos
Expression, structure, and function of androgen receptor in advanced prostatic carcinoma
Z Culig1, A Hobisch, A Hittmair
1Department of Urology, University of Innsbruck, Austria.
The Prostate
|April 16, 1998
Summary
Prostate tumors adapt to low androgen conditions by developing a hyperactive androgen receptor. This involves mutations, increased expression, and cross-talk with other signaling pathways for cancer progression.
Area of Science:
- Oncology
- Endocrinology
- Molecular Biology
Background:
- Endocrine therapy for prostate cancer targets androgen levels or androgen receptor (AR) action.
- While AR downregulation was suspected, AR is expressed across all prostate cancer stages.
- Mutant ARs and AR activation under low androgen conditions are critical factors.
Purpose of the Study:
- To review current literature on androgen receptor expression in prostate cancer.
- To explore structural and functional alterations of the AR.
- To examine AR signaling pathway interactions with other cellular pathways.
Main Methods:
- Literature review of in vitro and in vivo studies.
- Analysis of structural and functional AR alterations.
- Investigation of AR signaling pathway crosstalk.
Main Results:
- Prostate tumors exhibit AR hyperactivity in low androgen environments.
- Mechanisms include AR mutations leading to broader activation spectra.
- Increased AR expression and activation via other signaling pathways are observed.
Conclusions:
- Prostate cancer adapts to androgen deprivation through AR hyperactivity.
- Mutations, amplified expression, and pathway interactions enable tumor survival and progression.
- Understanding these adaptive mechanisms is key for future therapies.